» Articles » PMID: 14596803

The Remarkable Flexibility of the Human Antibody Repertoire; Isolation of over One Thousand Different Antibodies to a Single Protein, BLyS

Overview
Journal J Mol Biol
Publisher Elsevier
Date 2003 Nov 5
PMID 14596803
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

It is well established that the humoral immune response can generate antibodies to many different antigens. The antibody diversity required to achieve this is believed to be substantial. However, the extent to which the immune repertoire can generate structural diversity against a single target antigen has never been addressed. Here, we have used phage display to demonstrate the extraordinary capacity of the human antibody repertoire. Over 1000 antibodies, all different in amino acid sequence, were generated to a single protein, B-lymphocyte stimulator (BLyS protein). This is a highly diverse panel of antibodies as exemplified by the extensive heavy and light chain germline usage: 42/49 functional heavy chain germlines and 19/33 V(lambda) and 13/35 V(kappa) light chain germlines were all represented in the panel of antibodies. Moreover, a high level of sequence diversity was observed in the V(H) CDR3 domains of these antibodies, with 568 different amino acid sequences identified. Thus we have demonstrated that specific recognition of a single antigen can be achieved from many different VDJ combinations, illustrating the remarkable problem-solving ability of the human immune repertoire. When studied in a biochemical assay, around 500 (40%) of these antibodies inhibited the binding of BLyS to its receptors on B-cell lines. The most potent antibodies inhibited BLyS binding with sub-nanomolar IC(50) values and with sub-nanomolar affinities. Such antibodies provide excellent choices as candidates for the treatment of BLyS-associated autoimmune diseases.

Citing Articles

Breaking barriers in antibody discovery: harnessing divergent species for accessing difficult and conserved drug targets.

Banik S, Kushnir N, Doranz B, Chambers R MAbs. 2023; 15(1):2273018.

PMID: 38050985 PMC: 10793698. DOI: 10.1080/19420862.2023.2273018.


Understanding and Modulating Antibody Fine Specificity: Lessons from Combinatorial Biology.

Rojas G Antibodies (Basel). 2022; 11(3).

PMID: 35892708 PMC: 9326607. DOI: 10.3390/antib11030048.


Antibody Libraries as Tools to Discover Functional Antibodies and Receptor Pleiotropism.

Lin C, Lerner R Int J Mol Sci. 2021; 22(8).

PMID: 33923551 PMC: 8073236. DOI: 10.3390/ijms22084123.


Rational antibody design for undruggable targets using kinetically controlled biomolecular probes.

Trkulja C, Jungholm O, Davidson M, Jardemark K, Marcus M, Hagglund J Sci Adv. 2021; 7(16).

PMID: 33863724 PMC: 8051879. DOI: 10.1126/sciadv.abe6397.


The biology of ergothioneine, an antioxidant nutraceutical.

Borodina I, Kenny L, McCarthy C, Paramasivan K, Pretorius E, Roberts T Nutr Res Rev. 2020; 33(2):190-217.

PMID: 32051057 PMC: 7653990. DOI: 10.1017/S0954422419000301.